ProShares Ultra Nasdaq Biotechnology
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.95
資產淨值: 116.17
成立日期: 06/04/2010
 
分析
市值分佈:
52.83%
大市值
4.35%
中市值
1.63%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 248  
0%
 
100%
     10大 (27.95%)
代號 名稱 佔比% ▼ 持有日期
TECXTectonic Therapeutic Inc.0.0130/10/2026
EDITEditas Medicine0.0130/09/2026
OBIOOrchestra BioMed Holdings0.0130/10/2026
KYTXKyverna Therapeutics0.0130/10/2026
SPRYARS Pharmaceuticals0.0130/10/2026
AVIRAtea Pharmaceuticals0.0130/10/2026
ARCTArcturus Therapeutics Holdings0.0130/10/2026
ENTAEnanta Pharmaceuticals0.0130/10/2026
CTNMContineum Therapeutics0.0130/10/2026
AUTLAutolus Therapeutics plc0.0130/10/2026
QSIQuantum-Si0.0130/10/2026
FULCFulcrum Therapeutics0.0130/10/2026
LYELLyell Immunopharma Inc0.0130/10/2026
BIOABioAge Labs Inc.0.0130/10/2026
RCKTRocket Pharmaceuticals0.0130/10/2026
EYPTEyePoint Inc.0.0130/09/2026
LXEOLexeo Therapeutics0.0130/10/2026
LRMRLarimar Therapeutics0.0130/10/2026
CABACabaletta Bio0.0130/10/2026
IMRXImmuneering Corp0.0130/10/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.